Background: Fetal midgut volvulus is a rare disease, with a high risk of potentially life-threatening fetal complications.Purpose: The aim of this study was to retrospectively analyze the imaging findings of fetal midgut volvulus diagnosed by magnetic resonance imaging (MRI) and explore its value in non-invasive prenatal diagnosis.Methods: A retrospective collection of data from 156 fetuses suspected of intestinal obstruction by ultrasound examination in our hospital was conducted. All ultrasound examinations showed fetal intestinal dilation and fetal MRI diagnosis suspected midgut volvulus in 32 cases (32/156), of which 18 cases (18/32) that underwent surgical treatment in the neonatal period were confirmed to have midgut volvulus. MRI signs in the 18 fetuses with midgut volvulus were analyzed.Results: During MRI examination, all 18 fetuses showed gastric and/or intestinal dilatation, most of which showed different degrees of obstruction in T1-weighted images (WIs) and T2WIs, showing the “black and white sign” (14/18), “whirlpool sign” (10/18), and “coffee bean sign” (6/18). High signal intensity changes in diffusion-weighted imaging sequences were observed in intestinal tubes with ischemia and infarction. Direct signs of vascular torsion were observed in some cases (8/18). MRI signs indicated fetal midgut volvulus with hydramnios (16/18), meconium pseudocyst (7/18), meconium peritonitis (4/18), testicular hydrocele (3/18), and secondary pulmonary dysplasia (6/18). Operations confirmed the diagnosis of segmental midgut volvulus in 15 cases, complete midgut volvulus in 3 cases, and combined with intestinal atresia in 8 cases.Conclusion: Prenatal MRI plays an important role in the diagnosis of fetal midgut volvulus and the discovery of its complications, which can guide the treatment after birth and provide a reference for the prognosis.
4 October 2025 in Journal of Magnetic Resonance Imaging
Objectives: Central nervous system vasculitis (CNSV) is a rare disease. High-resolution vessel wall imaging (HR-VWI) enables the identification of inflammatory changes within the vessel wall. Few studies have applied HR-VWI to assess CNSV in children. This study delves into the utility of HR-VWI for diagnosing and treating CNSV in children, with the aim of enhancing clinical diagnosis and efficacy evaluation. Methods: Imaging data were acquired from children who underwent HR-VWI examinations. The study meticulously analysed clinical data and laboratory tests to discern the characteristics and distribution patterns of diverse vasculitis forms. Results: In children, CNSV mainly involves medium vessels with grade 1 and 2 stenosis (grade 4 stenosis is rare), and the imaging features generally show centripetal and moderate enhancement, suggesting that this feature is specific for the diagnosis of CNSV. High-grade stenosis, concentric enhancement and strong enhancement of the vasculature indicate more severe disease activity. Remarkably, HR-VWI proved to be significantly more sensitive than magnetic resonance angiography in detecting CNSV. Among the 13 cases subjected to imaging review, 8 demonstrated a reduction or resolution of vessel wall inflammation. In contrast, five patients exhibited worsening inflammation in the vessel wall. HR-VWI demonstrated that changes in vessel wall inflammation were closely correlated with changes in brain parenchymal lesions and symptoms. Conclusion: This study underscores the diagnostic value of HR-VWI in CNSV assessment and treatment monitoring, offering a quantitative evaluation of CNSV in children.
The different grading systems for diabetic foot disease pose a challenge in clinical decision making because each system fails to accurately reflect the individual course of disease progression. This study attempts to identify laboratory measurements for classifying diabetic foot disease to guide clinical treatment. The sera of 111 clinically graded diabetic foot patients were measured for several laboratory parameters including serum amyloid A (SAA), C-reactive protein (CRP), and apo A-I. By using the molar sum of CRP and SAA and then dividing by the molarity of apo A-I, an acute phase index was introduced to assess the inflammatory status of the patients. Based on a newly defined acute phase index (API), diabetic foot patients were classified into 3 distinct groups that provide a diagnostic tool complementing the established Texas grading system for clinical decision making. The integration of the serum concentrations of SAA, CRP and apo A-I into an acute phase index (API) offers an opportunity to triage diabetic foot patients who may benefit from personalized medicine.